Effect of tocilizumab treatment in mildly-obese patients with coronavirus disease 2019: a case series

BACKGROUND: The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an increasingly widespread international medical problem. Several randomized trials and observational studies in patients with COVID-19 have been performed. However, the stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Takashi, Yamaguchi, Fumihiro, Sakakura, Shunsuke, Yamazaki, Yohei, Shikama, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816833/
https://www.ncbi.nlm.nih.gov/pubmed/36618789
http://dx.doi.org/10.21037/atm-2022-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816833/
https://www.ncbi.nlm.nih.gov/pubmed/36618789
http://dx.doi.org/10.21037/atm-2022-49

Ejemplares similares